Gastro-Hep News

US Food and Drug Administration Approves Infliximab Biosimilar On December 14, 2017, the US Food and Drug Administration (FDA) approved the infliximab (Remicade, Janssen) biosimilar infliximab-qbtx […]

“Potassium-Competitive Acid Blockers and Gastroesophageal Reflux Disease” with David Armstrong, MA, MB BChir… https://t.co/YawOvRycG4

12 months ago
“Examining the New Definition of Hepatorenal Syndrome and the Role of Terlipressin” with Robert S. Brown Jr, MD, MPH https://t.co/ETH9dEBCqq

1 year ago
“Racial and Ethnic Disparities in Inflammatory Bowel Disease” with Marie L. Borum, MD, EdD, MPH https://t.co/aXb4g30iVx #IBD

1 year ago
“Update on Barrett Esophagus Diagnosis and Management” with Amitabh Chak, MD https://t.co/aP9L031PxP

1 year ago